Floatz logo

Gralise

Ulcerative Colitis

Shirley Ryan AbilityLabPhase 4 / ApprovedDormant
B
60/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
45/ 100
Competitive Position
89/ 100

Competitive context

13 Active assets in the Ulcerative Colitis cohort.

Asset / SponsorPhaseRating
Oxygen
Jay C. Buckey Jr.
Phase 4BB
Hextend
Corewell Health West
Phase 3B
Mesalamine
Shire
Phase 3B
Mmx Mesalamine/Mesalazine
Shire
Phase 3B
Nivolumab
Diwakar Davar
Phase 2B

View all 30 →

Same molecule, other indications

Gralise is also rated in:

irritable bowel syndromeDormant
B
Indicative ·
60 / 100
View asset →
interstitial cystitisDormant
B
Indicative ·
60 / 100
View asset →
chronic prostatitisDormant
B
Indicative ·
60 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →